Paid Clinical Trials in Philadelphia, PA

Browse 100 Paid Studies Philadelphia Across 832 Cities
38 Phase 3 Trial · 4199 Paid Studies Philadelphia Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in Philadelphia, PA

Reviewed by Michael Gill, B. Sc.

Image of Sutter Auburn Faith Hospital in Auburn, United States.

10 Paid Studies Philadelphia Near Me

Top Cities for Paid Studies Philadelphia

Philadelphia

121Active Trials

Thomas Jefferson UniversityTop Active Site

New York

86Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site

Paid Studies Philadelphia by Phase of Trial

N/A Paid Studies Philadelphia

14Active Paid Studies Philadelphia

14Number of Unique Treatments

387Number of Active Locations

Eye Patch Multiparametric Magnetic Resonance Imaging Phototherapy lights Optune®Non-Randomized Absolute Contraindication to Thrombolytics Cohort Intervention CCAPB (intervention)BCCU Usual COPD care SQUID Advance Care Planning Video Decision Aid Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature Prolonged Exposure Therapy Pembrolizumab

Most Recent Paid Studies Philadelphia

Clinical Trial

Began Recruiting Date

Phase

CCAPB (intervention) for Premature Birth

7/17/2023

N/A

Obinutuzumab for Vasculitis

6/30/2023

Phase 2

BBP-418 for Limb-Girdle Muscular Dystrophy

5/31/2023

Phase 3

Ziltivekimab 15 mg for Heart Failure

5/8/2023

Phase 3

Arm I (selumetinib, olaparib) for Endometrial Cancer

4/25/2023

Phase 2

About The Author

Michael Gill - B. Sc.

First Published: October 16th, 2021

Last Reviewed: August 24th, 2023

References¹ Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. Review. https://pubmed.ncbi.nlm.nih.gov/31401903² Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. https://pubmed.ncbi.nlm.nih.gov/31401903³ Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. https://pubmed.ncbi.nlm.nih.gov/10793162⁴ Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801. https://pubmed.ncbi.nlm.nih.gov/10793162⁵ Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801. https://pubmed.ncbi.nlm.nih.gov/10793162⁶ Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20. https://pubmed.ncbi.nlm.nih.gov/23688302⁷ Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20. https://pubmed.ncbi.nlm.nih.gov/23688302⁸ Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guérin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372. https://pubmed.ncbi.nlm.nih.gov/20843245⁹ Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. https://pubmed.ncbi.nlm.nih.gov/32142651¹⁰ Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guerin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372. https://pubmed.ncbi.nlm.nih.gov/20843245